DSIP 2mg

DSIP (Delta Sleep-Inducing Peptide) is a neuropeptide that plays a role in regulating sleep and various physiological processes. First discovered in the 1970s, DSIP was found in the hypothalamus and has been associated with promoting delta-wave sleep, which is the deep, restorative stage of sleep.

“Content & Potency: 1000mcg/ml subcutaneous injectable provided in a 3ml vial. Suggested dosage: Inject 0. 1ml subcutaneously once daily 2-3 times per week.”

“DSIP-more than a sleep peptide! In several species DSIP at low doses has been shown to promote sleep. Although its physiological role remains to be clarified, DSIP illustrates several concepts applicable to other brain peptides. These include the bellshaped dose-response curve, central effects after peripheral administration, a delayed and prolonged time course, and some penetration of the blood-brain barrier in essentially intact form.
Concepts applicable to one neuropeptide, therefore, appear to be applicable to others. In this article Abba Kastin and colleagues review the known effects of DSIP and argue that more work needs to be carried out before it can be labelled functionally. J. Kastin, Abba & A. Olson, Gayle & V. Schally, Andrew & H. Coy, David. (1980). DSIP — more than a sleep peptide?. Trends in Neurosciences – TRENDS NEUROSCI. 3. 163-165.”